Deepta Bhattacharya, PhD, professor of immunobiology at the College of Medicine – Tucson, said there was evidence vaccine effectiveness is “slipping against omicron” in some age groups—notably older people and kids between 5 and 11—and that vulnerable people who were boosted months ago “may want to get another dose,” but for anyone else “it’s a choice” and probably not needed.

Kate Ellingson, PhD, an assistant professor at the Mel and Enid Zuckerman College of Public Health, said BA.2’s impact on overall case numbers will depend on several other factors, including underlying immunity from previous infection and vaccination and how much people take precautions.

Researchers will target cancer health disparities unique to Hispanic communities by addressing the root causes to accelerate progress in health equity research.

Fourth-year University of Arizona College of Medicine – Tucson students learned where they’ll launch their careers as new residents.

Lacking access to regular, preventive health care can lead to a higher burden of untreated chronic disease and put people at higher risk if they are infected with a virus such as SARS-CoV-2, which causes COVID-19. Shad Marvasti, MD, associate professor of family and community medicine at the College of Medicine – Phoenix, is quoted.

The population of older adults continues to increase in the United States and in Arizona. The University of Arizona Health Sciences just launched a graduate program to learn more about this growing demographic.

As the temperature throughout Arizona begins to tick upwards this time of year, so too comes the return of venomous snakes, spiders, and scorpions. Thankfully with modern medicine, fatalities from reptile bites are extremely rare. According to the UArizona Poison and Drug Information Center, the recent death rate has dropped to less than 1%.

People living in economically distressed parts of Pima County, as well as those in rural areas and tribal lands throughout southern Arizona, are experiencing greater health challenges due to the pandemic. Students and faculty at the College of Medicine – Tucson are quoted.

The addition of pembrolizumab to chemotherapy, with or without bevacizumab, in women with persistent, recurrent or metastatic cervical cancer was linked with better quality of life, reported Bradley J. Monk, MD, FACS, FACOG, a professor of obstetrics and gynecology at the College of Medicine – Phoenix.